Trial Profile

An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 05 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin lispro (Primary)
Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
Focus Therapeutic Use
Sponsors Eli Lilly and Company

Most Recent Events

25 Sep 2020 Results presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
25 Sep 2020 Results evaluaitng differences between T1D and T2D participants regarding the association between hypoglycemic fear and missed bolus doses frequency, presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
26 Jul 2018 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com